Gene therapy in head and neck cancer: a review

被引：15
|
作者：
Chisholm, E.
Bapat, U.
Chisholm, C.
Alusi, G.
Vassaux, G.
机构：
[1] Londo NHS Trust, Canc Res UK, London, England
[2] Barts & Londo NHS Trust, Dept ENT, London, England
[3] Charing Cross Hosp, Dept Clin Oncol, London, England
来源：
POSTGRADUATE MEDICAL JOURNAL | 2007年 / 83卷 / 986期
关键词：
D O I：
10.1136/pgmj.2007.061994
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gene therapy for cancer is a rapidly evolving field with head and neck squamous cell cancer being one of the more frequently targeted cancer types. The number of clinical trials in the UK is growing and there is already a commercially available agent in China. Various gene therapy strategies along with delivery mechanisms for targeting head and neck cancer are reviewed.
引用
收藏
页码：731 / 737
页数：7
相关论文
共 50 条
  • [21] Gene therapy for head and neck cancers
    Lamont, JP
    Kuhn, JA
    Nemunaitis, JJ
    McCarty, TM
    ONCOLOGY-NEW YORK, 2001, 15 (03): : 303 - 308
  • [22] Impact of Acid Ceramidase Expression on Head and Neck Cancer Proliferation, a Novel Target for Head and Neck Gene Therapy
    Liu, Xiang
    Marrison, Sarah Tucker
    Meacham, William D.
    McPherson, Alex
    Cheng, Joe
    Turner, Lorianne S.
    Day, Terry
    Hannun, Yusuf A.
    Norris, James S.
    MOLECULAR THERAPY, 2009, 17 : S104 - S104
  • [23] FasL gene therapy: a new therapeutic modality for head and neck cancer
    S ElOjeimy
    J C McKillop
    A M El-Zawahry
    D H Holman
    X Liu
    D A Schwartz
    T A Day
    J-Y Dong
    J S Norris
    Cancer Gene Therapy, 2006, 13 : 739 - 745
  • [24] DEVELOPING A NOVEL GENE-THERAPY FOR HEAD AND NECK-CANCER
    LIU, TJ
    TAYLOR, DL
    ZHANG, WW
    ROTH, JA
    GEOPFERT, H
    CLAYMAN, GL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 425 - 425
  • [25] FasL gene therapy: a new therapeutic modality for head and neck cancer
    ElOjeimy, S.
    McKillop, J. C.
    El-Zawahry, A. M.
    Holman, D. H.
    Liu, X.
    Schwartz, D. A.
    Day, T. A.
    Dong, J. -Y.
    Norris, J. S.
    CANCER GENE THERAPY, 2006, 13 (08) : 739 - 745
  • [26] Considerations of somatic gene therapy in head and neck squamous cell cancer
    Wollenberg, B
    Naujoks, K
    Kastenbauer, E
    LARYNGO-RHINO-OTOLOGIE, 1996, 75 (06) : 356 - 362
  • [27] Inducible promoters for gene therapy of head and neck cancer: an in vitro study
    Marianne Schmidt
    Tonja Heimberger
    Petra Gruensfelder
    Gabriele Schler
    Florian Hoppe
    European Archives of Oto-Rhino-Laryngology and Head & Neck, 2004, 261 : 208 - 215
  • [28] Inducible promoters for gene therapy of head and neck cancer: an in vitro study
    Schmidt, M
    Heimberger, T
    Gruensfelder, P
    Schler, G
    Hoppe, F
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2004, 261 (04) : 208 - 215
  • [29] Alloantigen gene therapy for head and neck cancer: Evaluation of animal models
    Gleich, LL
    Li, YQ
    Li, SN
    Gluckman, JL
    Stambrook, PJ
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (04): : 274 - 279
  • [30] Intraoperative radiation therapy (IORT) in head and neck cancer A systematic review
    Kyrgias, George
    Hajiioannou, Jiannis
    Tolia, Maria
    Kouloulias, Vassilios
    Lachanas, Vasileios
    Skoulakis, Charalambos
    Skarlatos, Ioannis
    Rapidis, Alexandros
    Bizakis, Ioannis
    MEDICINE, 2016, 95 (50) : e5035
12345